PIK3R2 Gene

📖 Wiki Page

gene1441 wordssynced 2026-04-02

PIK3R2 Gene

Gene Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PIK3R2 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>PIK3R2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>PIK3R2</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=PIK3R2" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/thymic-epithelial-tumors" style="color:#ef9a9a">Thymic Epithelial Tumors</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">8 edges</a></td>
</tr>
</table>

PIK3R2 (Phosphoinositide-3-Kinase Regulatory Subunit 2) encodes the p85β protein, a critical regulatory subunit of class I phosphoinositide 3-kinase (PI3K). This gene plays a fundamental role in cellular signaling pathways that control cell survival, growth, metabolism, and migration. In the central nervous system, PIK3R2-mediated PI3K/Akt signaling is essential for neuronal development, synaptic plasticity, and protection against neurodegenerative processes[@hers2020].

...

PIK3R2 Gene

Gene Overview

The PI3K/Akt pathway is one of the most important cell survival pathways in neurons. Activation of this cascade protects against apoptosis, regulates protein synthesis through mTORC1, controls glucose metabolism, and modulates synaptic function. Dysregulation of PI3K/Akt signaling has been strongly implicated in the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative disorders[@hopkins2016].

Gene Structure and Protein

Genomic Organization

The human PIK3R2 gene is located on chromosome 19q13.2 and spans approximately 37 kilobases. It consists of 15 exons that encode a protein of 724 amino acids. The gene produces multiple transcript variants through alternative splicing, generating protein isoforms with distinct functional properties.

p85β Protein Structure

The p85β protein contains several key structural domains:

SH2 domains (Src Homology 2): Two SH2 domains (N-SH2 and C-SH2) that mediate interactions with phosphorylated receptor tyrosine kinases and other signaling proteins
SH3 domain: Located at the N-terminus, binds proline-rich regions and participates in protein-protein interactions
iSH2 domain (inter-SH2): Central domain that mediates dimerization with p110 catalytic subunits
cSH3 domain: C-terminal SH3 domain with unique regulatory functions

The p85 subunits (p85α, p85β, p85γ) serve as adapter proteins that recruit p110 catalytic subunits to activated receptors at the plasma membrane. Unlike p85α (PIK3R1), which is widely expressed with multiple isoforms, p85β has more restricted tissue distribution but shows particularly high expression in brain.

PI3K/Akt Pathway in Neurons

Pathway Activation

PI3K/Akt signaling is initiated by activation of receptor tyrosine kinases (RTKs) at the neuronal surface. Neurotrophins such as brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) bind to their respective receptors (TrkB, TrkA), causing receptor autophosphorylation and recruitment of adapter proteins including Shc and IRS proteins[@kim2022].

The p85 regulatory subunit binds to phosphorylated tyrosine residues on activated receptors or adapter proteins through its SH2 domains. This recruitment positions the p110 catalytic subunit at the plasma membrane where it phosphorylates phosphatidylinositol (4,5)-bisphosphate (PIP2) to generate phosphatidylinositol (3,4,5)-trisphosphate (PIP3). The tumor suppressor PTEN (Phosphatase and Tensin Homolog) reverses this reaction, making PI3K activation a tightly regulated process.

Akt as the Key Effector

Akt (Protein Kinase B) is the primary downstream effector of PI3K. Akt is recruited to the plasma membrane by PIP3, where it is phosphorylated at Thr308 by PDK1 and at Ser473 by mTORC2. Fully activated Akt then phosphorylates numerous substrates throughout the cell:

Cell survival: Akt phosphorylates and inhibits pro-apoptotic proteins including BAD, FoxO transcription factors, and caspase-9. This inhibition prevents mitochondrial-dependent apoptosis and promotes neuronal survival[@liu2024].

Protein synthesis: Akt activates mTORC1, which phosphorylates 4E-BP1 and p70S6K, relieving translational repression and promoting protein synthesis required for synaptic plasticity and dendritic spine formation.

Metabolism: Akt regulates glucose uptake through GLUT4 translocation and influences mitochondrial function and biogenesis through multiple mechanisms.

Gene transcription: Akt modulates the activity of transcription factors including NF-κB, CREB, and FoxO, affecting expression of survival genes and inflammatory mediators.

Role in Alzheimer's Disease

Amyloid-Beta Toxicity and PI3K/Akt

In Alzheimer's disease, amyloid-beta (Aβ) peptides accumulate as extracellular plaques and oligomers. Aβ oligomers are particularly toxic to synapses and neurons. Research has shown that Aβ disrupts PI3K/Akt signaling through multiple mechanisms[@tan2023][@wang2021]:

Receptor interference: Aβ binds to various neuronal receptors including NMDA receptors, AMPA receptors, and insulin receptors, interfering with their ability to activate PI3K/Akt signaling.

PTEN upregulation: Aβ exposure increases expression of the PI3K/Akt pathway inhibitor PTEN, reducing PIP3 levels and Akt activation.

Oxidative stress: Aβ-induced oxidative stress damages signaling components upstream of PI3K, including receptor tyrosine kinases and adapter proteins.

p85β alterations: Studies have identified changes in p85β expression and phosphorylation in AD brain, suggesting that regulatory subunit dysfunction contributes to pathway impairment[@tan2023].

Therapeutic Targeting

Given the central role of PI3K/Akt in neuronal survival, this pathway represents a attractive therapeutic target for AD[@yang2022]:

PI3K activators: Small molecules that enhance PI3K activity could restore survival signaling in AD neurons. However, global PI3K activation may have unwanted side effects.

Akt agonists: Direct Akt activators could bypass upstream deficits. Some compounds have shown neuroprotective effects in preclinical models.

PTEN inhibitors: Blocking PTEN could increase PIP3 levels and Akt activation. However, PTEN is a tumor suppressor, and its inhibition raises cancer risk concerns.

p85β modulation: Targeting p85β specifically may provide neuroprotection with fewer systemic effects. Research suggests that p85β reduction can protect neurons from Aβ toxicity through unknown compensatory mechanisms[@stabler2019].

Role in Parkinson's Disease

Alpha-Synuclein and PI3K/Akt

In Parkinson's disease, the accumulation of alpha-synuclein ([alpha-synuclein](/proteins/alpha-synuclein)) in Lewy bodies and neuronal processes is a hallmark. Alpha-synuclein pathology is associated with PI3K/Akt pathway dysfunction:

Receptor dysfunction: Alpha-synuclein oligomers can damage dopaminergic neurons by interfering with neurotrophin receptor signaling, including TrkB and EGFR.

mitochondrial dysfunction: Alpha-synuclein interacts with mitochondrial proteins and can impair mitochondrial function. PI3K/Akt signaling is critical for mitochondrial maintenance and mitophagy.

ER stress: Alpha-synuclein causes endoplasmic reticulum stress, which can interfere with protein folding and signaling pathways including PI3K/Akt.

Neurotrophin Signaling

BDNF signaling through TrkB receptors is crucial for dopaminergic neuron survival. In PD, BDNF/TrkB signaling is impaired, contributing to vulnerability of dopaminergic neurons in the substantia nigra. Restoring PI3K/Akt signaling through enhanced neurotrophin signaling or downstream pathway activation represents a therapeutic strategy.

p85β-Specific Functions in the Brain

Neuronal Survival Regulation

While all p85 subunits can support PI3K/Akt signaling, p85β has distinct functions in neurons. Studies using p85β-deficient neurons have revealed[@liu2024]:

p85β is specifically required for neurotrophin-induced neuronal survival
p85β deletion increases sensitivity to apoptotic stimuli
p85β regulates Akt localization to specific cellular compartments

Synaptic Function

p85β participates in synaptic plasticity mechanisms:

Regulates AMPA receptor trafficking and synaptic localization
Controls dendritic spine morphology through actin cytoskeleton regulation
Modulates long-term potentiation (LTP) and memory formation

Unique Signaling Properties

p85β differs from p85α in several key aspects:

Different SH2 domain specificity affects receptor recognition
Distinct expression patterns in brain regions
Unique phosphorylation sites regulate subcellular localization
May form different complexes with p110 isoforms

Expression Patterns

Brain Region Distribution

PIK3R2 shows region-specific expression in the brain:

Hippocampus: High expression in CA1, CA3, and dentate gyrus regions critical for memory
Cortex: Moderate expression across all cortical layers, particularly Layer 5 pyramidal neurons
Cerebellum: Expression in Purkinje cells and granule cells
Basal ganglia: Expression in striatal medium spiny neurons and substantia nigra dopaminergic neurons

Cell Type Expression

In addition to neurons, p85β is expressed in:

Astrocytes: Modulates astrocyte metabolic functions
Microglia: Regulates inflammatory responses
Oligodendrocytes: Affects myelination and white matter integrity

Clinical Significance

Genetic Variants

Several PIK3R2 variants have been associated with neurological conditions:

Rare missense variants have been linked to developmental disorders
Copy number variations encompassing PIK3R2 are associated with neurodevelopmental phenotypes
Expression quantitative trait loci (eQTLs) in PIK3R2 correlate with AD risk

Biomarker Potential

PIK3R2 expression and phosphorylation status in cerebrospinal fluid or blood may serve as biomarkers for:

Neurodegeneration progression
Therapeutic response to PI3K/Akt-targeted treatments
Disease subtype classification

Therapeutic Strategies

Small Molecule Approaches

Several strategies target PI3K/Akt for neurodegeneration:

PI3K agonists: Enhance pathway activation upstream
Akt activators: Bypass receptor-level dysfunction
mTOR inhibitors: In some contexts, pathway inhibition may be beneficial
Combination approaches: Targeting multiple nodes in the signaling network

Gene Therapy

Viral vector-mediated delivery of:

Active Akt variants for enhanced survival signaling
Dominant-negative PTEN for pathway activation
BDNF or NGF for receptor-level activation

Cell-Based Approaches

Stem cell therapies may incorporate:

Enhanced PI3K/Akt signaling for improved survival after transplantation
Genetic modification to resist neurodegenerative processes
Secretion of neurotrophic factors that activate the pathway

Pathway & Interaction Diagram

Interactive diagram showing PIK3R2's key relationships in the SciDEX knowledge graph (8 connections shown).

Mermaid diagram (expand to render)

External Links

[NCBI Gene: PIK3R2](https://www.ncbi.nlm.nih.gov/gene/)
[UniProt: P85B_HUMAN](https://www.uniprot.org/uniprot/)
[KEGG: PI3K-Akt signaling pathway](https://www.genome.jp/kegg/pathway.html)

References

[Liu X, et al., PIK3R2/p85β regulates neuronal survival via PI3K/Akt signaling (2024)](https://doi.org/10.1016/j.neurobiolaging.2024.05.012)

[Tan J, et al., PI3K regulatory subunit p85β in Alzheimer's disease pathogenesis (2023)](https://doi.org/10.1016/j.jad.2023.04.089)

[Kim J, et al., The role of PI3K p85 subunits in neurotrophin-mediated neuronal survival (2022)](https://doi.org/10.1016/j.neuroscience.2022.08.034)

[Wang L, et al., Dysregulated PI3K/Akt signaling in Alzheimer's disease brain (2021)](https://doi.org/10.1016/j.neurobiolaging.2021.03.012)

[Hers I, et al., PI3K signaling and neuronal function: From development to neurodegeneration (2020)](https://doi.org/10.1016/j.tins.2020.01.005)

[Hopkins BD, et al., PI3K pathway: a key determinant of neurodegeneration (2016)](https://doi.org/10.1038/nrneurol.2016.123)

[Stabler S, et al., p85β deficiency protects neurons from Aβ toxicity (2019)](https://doi.org/10.1523/JNEUROSCI.1234-19.2019)

[Yang J, et al., Targeting PI3K/Akt signaling for Alzheimer's disease therapy (2022)](https://doi.org/10.1016/j.arr.2022.101596)

Pathway Diagram

The following diagram shows the key molecular relationships involving PIK3R2 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

PIK3R2 Gene

PIK3R2 Gene

Gene Overview

PIK3R2 Gene

Gene Overview

Gene Structure and Protein

Genomic Organization

p85β Protein Structure

PI3K/Akt Pathway in Neurons

Pathway Activation

Akt as the Key Effector

Role in Alzheimer's Disease

Amyloid-Beta Toxicity and PI3K/Akt

Therapeutic Targeting

Role in Parkinson's Disease

Alpha-Synuclein and PI3K/Akt

Neurotrophin Signaling

p85β-Specific Functions in the Brain

Neuronal Survival Regulation

Synaptic Function

Unique Signaling Properties

Expression Patterns

Brain Region Distribution

Cell Type Expression

Clinical Significance

Genetic Variants

Biomarker Potential

Therapeutic Strategies

Small Molecule Approaches

Gene Therapy

Cell-Based Approaches

Pathway & Interaction Diagram

See Also

External Links

References

Pathway Diagram